This segment encompasses the research, development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products. R&D activities focus on key therapeutic areas including metabolic and digestive systems, antitumor, anti-infective, central nervous system, cardiovascular system, blood system, and vaccines. The company utilizes advanced technologies such as AI-driven drug discovery platforms (PharmAID) to accelerate the identification and development of novel drug candidates. This segment addresses significant unmet medical needs and aims to improve patient outcomes through innovative therapies. Market positioning is strong in China, with increasing international presence through strategic partnerships. Future opportunities include expanding the product pipeline, particularly in innovative drugs, and strengthening global market access. Regulatory compliance and clinical trial management are critical aspects of this segment, with a focus on obtaining approvals from NMPA and other international regulatory bodies. Partnerships with Teva and Amgen are examples of collaborations to accelerate drug development and market reach.

This segment focuses on the development, manufacturing, and sales of medical devices and in vitro diagnostic (IVD) products. The product portfolio includes a wide range of devices and diagnostic tools used in clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, and clinical microbiology. The company leverages advanced technologies such as molecular diagnostics and gene chip technology to provide accurate and timely diagnostic solutions. This segment aims to improve patient care through early and accurate disease detection and monitoring. Market positioning is strong in China, with a focus on providing high-quality and innovative medical devices. Future opportunities include expanding the product portfolio, particularly in high-growth areas such as molecular diagnostics and point-of-care testing. Regulatory compliance and obtaining necessary certifications are crucial for market access. The company is actively involved in research and development to enhance the performance and accuracy of its diagnostic products.

This segment provides comprehensive healthcare services, including hospital management and operation. The company operates and manages various hospitals, offering a wide range of medical services to patients. The focus is on delivering high-quality patient care and improving healthcare outcomes. This segment leverages advanced technologies and methodologies to enhance operational efficiency and improve patient experience. The therapeutic areas covered include a broad spectrum of medical specialties. The patient impact is significant, as the company strives to provide accessible and affordable healthcare services. Market positioning is strong in China, with a focus on expanding its network of hospitals and healthcare facilities. Future opportunities include expanding into new geographic markets and offering specialized medical services. Regulatory compliance and adherence to healthcare standards are critical aspects of this segment. The company is committed to providing high-quality healthcare services and improving the overall health and well-being of the communities it serves.